Abstract:Co-infection between HIV-1 and HCV is common today in certain populations. However, treatment of co-infection is full of challenges with special consideration for potential hepatic safety and drug-drug interactions. Multitarget inhibitors with less toxicity may provide a promising therapeutic strategy for HIV/HCV co-infection. However, identification of one molecule acting on multiple targets simultaneously by experimental evaluation is costly and time-consuming. In silico target prediction tools provide more opportunities for the development of multitarget inhibitors. In this study, by combining naive Bayesian (NB) and support vector machine (SVM) algorithms with two types of molecular fingerprints (MACCS and ECFP6), 60 classification models were constructed to predict the active compounds toward 11 HIV-1 targets and 4 HCV targets based on the multitarget-quantitative structure-activity relationships (mt-QSAR). 5-fold cross-validation and test set validation was performed to confirm the performance of 60 classification models. Our results show that 60 mt-QSAR models appeared to have high classification accuracy in terms of ROC-AUC values ranging from 0.83 to 1 with a mean value of 0.97 for HIV-1 models, and ROC-AUC values ranging from 0.84 to 1 with a mean value of 0.96 for HCV. Furthermore, the 60 models were applied to comprehensively predict the potential targets for additional 46 compounds including 27 approved HIV-1 drugs, 10 approved HCV drugs and 9 selected compounds known to be active on one or more targets of HIV-1 or those of HCV. Finally, 18 hits including 7 HIV-1 approved drugs, 4 HCV approved drugs and 7 compounds were predicted to be HIV/HCV co-infection multitarget inhibitors. The reported bioactivity data confirmed that 7 compounds actually interacted with HIV-1 and HCV targets simultaneously with diverse binding affinities. Of those remaining predicted hits and chemical-protein interaction pairs involving the potential ability to suppress HIV/HCV co-infection deserve further investigation by experiments. This investigation shows that the mt-QSAR method is available to predict chemical-protein interaction for discovering multitarget inhibitors and provide a unique perspective on HIV/HCV co-infection treatment.

Multi-task learning models for predicting active compounds

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

ADMET Property Prediction Via Multi-Task Graph Learning under Adaptive Auxiliary Task Selection

MTGL-ADMET: A Novel Multi-task Graph Learning Framework for ADMET Prediction Enhanced by Status-Theory and Maximum Flow.

Evaluation of multi-target deep neural network models for compound potency prediction under increasingly challenging test conditions

Comprehensive strategies of machine-learning-based quantitative structure-activity relationship models

Improved Graph‐based Multitask Learning Model with Sparse Sharing for Quantitative Structure–property Relationship Prediction of Drug Molecules

Neural multi-task learning in drug design

KG-MTL: Knowledge Graph Enhanced Multi-Task Learning for Molecular Interaction

An In Silico Method for Predicting Drug Synergy Based on Multitask Learning

Quantitative Structure Activity Relationship (qsar) Approach to Multiple Drug Resistance (mdr) Modulators Based on Combined Hybrid System

Uni-QSAR: an Auto-ML Tool for Molecular Property Prediction

Comprehensive ensemble in QSAR prediction for drug discovery

Pushing the Boundaries of Molecular Property Prediction for Drug Discovery with Multitask Learning BERT Enhanced by SMILES Enumeration

MultiDTI: Drug-Target Interaction Prediction Based on Multi-Modal Representation Learning to Bridge the Gap Between New Chemical Entities and Known Heterogeneous Network.

Docking-based Virtual Screening with Multi-Task Learning

Breaking the barriers of data scarcity in drug–target affinity prediction

Targeting against HIV/HCV Co-infection using Machine Learning-based multitarget-quantitative structure-activity relationships (mt-QSAR) Methods

Prediction of compound-target interaction using several artificial intelligence algorithms and comparison with a consensus-based strategy

Using Deep Learning for Compound Selectivity Prediction